HOME >> MEDICINE >> NEWS
UCI researchers identify first compound to block progression of Alzheimer's disease

Irvine, Calif. -- Researchers at UC Irvine have found that a new compound not only relieves the cognitive symptoms of Alzheimer's disease, but also reduces the two types of brain lesions that are hallmarks of this devastating disease, thereby blocking its progression.

In a study with genetically modified mice, a team of UCI researchers led by Frank LaFerla, professor of neurobiology and behavior, found that a compound known as AF267B, developed by paper co-author Abraham Fisher of the Israel Institute for Biological Research, reduced both plaque lesions and tangles in brain regions associated with learning and memory. Although drugs exist on the market today to treat the symptoms of Alzheimer's, AF267B represents the first disease-modifying compound, meaning it appears to affect the underlying cause and reduces the two signature lesions, plaques and tangles.

The researchers report their findings in the March 2 issue of Neuron.

"AF267B could be a tremendous step forward in the treatment of Alzheimer's disease," said LaFerla, who serves as co-director of the UCI Institute for Brain Aging and Dementia. "Not only does it appear to work on the pathology of Alzheimer's and ease its symptoms, it crosses the blood-brain barrier, which means it does not have to be directly administered to the brain, a significant advantage for a pharmaceutical product. Although we cannot determine what the effects of AF267B will be in humans until clinical trials are complete, we are very excited by the results our study has yielded."

According to LaFerla, AF267B works by mimicking the effects of the neurotransmitter acetylcholine, a chemical in the brain essential for learning and memory. Neurotransmitters act as carriers for messages between brain cells and bind to receptors on the cells' surfaces. Acetylcholine generally binds to specific receptors in the brain, including the M1 receptor, a potentially novel therapeutic target for Alzheimer's disease.
'"/>

Contact: Farnaz Khadem
fkhadem@uci.edu
949-824-5484
University of California - Irvine
1-Mar-2006


Page: 1 2 3 4 5

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
3. Penn researchers discover novel pathway for increasing good cholesterol
4. Theory of facial aging gets a facelift from UT Southwestern researchers
5. UIC researchers to develop new drugs to fight bioterrorism
6. UQ researchers discover some of the oldest forms of life
7. U of M researchers discover new method to combat HIV
8. U of M researchers assess effectiveness of computerized physician order entry system
9. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
10. Physician-researchers often less successful in obtaining NIH funding
11. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells

Post Your Comments:
(Date:7/2/2015)... ... ... Every year, DUI arrests and fatalities spike on the 4th of July. In fact, because ... when it comes to being on the road. According to attorney David J. Maloney ... of all highway deaths between 2007 and 2011 were caused by drunk driving over the ...
(Date:7/2/2015)... Liverpool, Ohio (PRWEB) , ... July 02, 2015 , ... ... as Director of the Surgical Center at East Liverpool City Hospital (ELCH). Pam is ... assume the duties of the director of surgery. Pam holds a master’s degree in ...
(Date:7/2/2015)... ... ... we consume can have an effect on the body. And during the hot summer season, ... if not eating enough of the right foods, as well as drinking plenty of water. ... it on the food front as well, with sweet treats like ice cream and snow cones ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... As part ... in Bangkok Thailand is expressing its gratitude to its patients from all around the ... Whether these are patients who are off on a dental tour (indeed, Thantakit is ...
(Date:7/2/2015)... ... , ... Cs &A, the leader in Semi Timing Industry ... publication of their newest offering to complement the existing line of Market Reporting ... in support of coverage for the full spectrum of Semi Timing solutions from ...
Breaking Medicine News(10 mins):Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Thailand's Longest Established International Dental Center Celebrates Its 70th Anniversary with Promos Galore 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4
(Date:7/1/2015)... -- Prismic Pharmaceuticals, Inc., a specialty pharmaceutical company developing ... the election of Joseph J. Krivulka and ... Directors. Commenting on the election of these ... and CEO of Prismic, stated, "We are delighted that ... have accepted our invitation to join Prismic,s Board of ...
(Date:7/1/2015)... , July 1, 2015 Dynatronics Corporation ... and marketer of rehabilitation and physical therapy products, ... private placement financing led by affiliates of Prettybrook ... investor focused on the healthcare industry. The financing ... growth and pursue potential strategic acquisitions.  ...
(Date:7/1/2015)... SHANGHAI , July 1, 2015 Qiming ... Hu to Managing Partner effective immediately. ... He has lead and participated in many Qiming healthcare ... leaders in the Chinese market. Qiming, s success in ... and he has distinguished himself with his outstanding advocacy ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Qiming Announces the Promotion of William Hu to Managing Partner 2
Cached News: